Global Hereditary Angioedema Treatment Market Insights and Forecast to 2031

Report ID: 1639417 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hereditary Angioedema Treatment Product Introduction
    1.2 Market by Type
        1.2.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
        1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
        1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
        1.2.5 Others (Conventional Drugs, Pipeline Drugs)
    1.3 Market by Application
        1.3.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Others (online pharmacies, mail pharmacies)
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts 2017-2028
    2.2 Global Hereditary Angioedema Treatment Revenue Estimates and Forecasts 2017-2028
    2.3 Global Hereditary Angioedema Treatment Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Hereditary Angioedema Treatment Sales by Region
        2.4.1 Global Hereditary Angioedema Treatment Sales by Region (2017-2022)
        2.4.2 Global Sales Hereditary Angioedema Treatment by Region (2023-2028)
    2.5 Global Hereditary Angioedema Treatment Revenue by Region
        2.5.1 Global Hereditary Angioedema Treatment Revenue by Region (2017-2022)
        2.5.2 Global Hereditary Angioedema Treatment Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Hereditary Angioedema Treatment Sales by Manufacturers
        3.1.1 Global Top Hereditary Angioedema Treatment Manufacturers by Sales (2017-2022)
        3.1.2 Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hereditary Angioedema Treatment in 2021
    3.2 Global Hereditary Angioedema Treatment Revenue by Manufacturers
        3.2.1 Global Hereditary Angioedema Treatment Revenue by Manufacturers (2017-2022)
        3.2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Hereditary Angioedema Treatment Revenue in 2021
    3.3 Global Hereditary Angioedema Treatment Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Hereditary Angioedema Treatment Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Hereditary Angioedema Treatment Sales by Type
        4.1.1 Global Hereditary Angioedema Treatment Historical Sales by Type (2017-2022)
        4.1.2 Global Hereditary Angioedema Treatment Forecasted Sales by Type (2023-2028)
        4.1.3 Global Hereditary Angioedema Treatment Sales Market Share by Type (2017-2028)
    4.2 Global Hereditary Angioedema Treatment Revenue by Type
        4.2.1 Global Hereditary Angioedema Treatment Historical Revenue by Type (2017-2022)
        4.2.2 Global Hereditary Angioedema Treatment Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2028)
    4.3 Global Hereditary Angioedema Treatment Price by Type
        4.3.1 Global Hereditary Angioedema Treatment Price by Type (2017-2022)
        4.3.2 Global Hereditary Angioedema Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Hereditary Angioedema Treatment Sales by Application
        5.1.1 Global Hereditary Angioedema Treatment Historical Sales by Application (2017-2022)
        5.1.2 Global Hereditary Angioedema Treatment Forecasted Sales by Application (2023-2028)
        5.1.3 Global Hereditary Angioedema Treatment Sales Market Share by Application (2017-2028)
    5.2 Global Hereditary Angioedema Treatment Revenue by Application
        5.2.1 Global Hereditary Angioedema Treatment Historical Revenue by Application (2017-2022)
        5.2.2 Global Hereditary Angioedema Treatment Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2017-2028)
    5.3 Global Hereditary Angioedema Treatment Price by Application
        5.3.1 Global Hereditary Angioedema Treatment Price by Application (2017-2022)
        5.3.2 Global Hereditary Angioedema Treatment Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Hereditary Angioedema Treatment Market Size by Type
        6.1.1 North America Hereditary Angioedema Treatment Sales by Type (2017-2028)
        6.1.2 North America Hereditary Angioedema Treatment Revenue by Type (2017-2028)
    6.2 North America Hereditary Angioedema Treatment Market Size by Application
        6.2.1 North America Hereditary Angioedema Treatment Sales by Application (2017-2028)
        6.2.2 North America Hereditary Angioedema Treatment Revenue by Application (2017-2028)
    6.3 North America Hereditary Angioedema Treatment Market Size by Country
        6.3.1 North America Hereditary Angioedema Treatment Sales by Country (2017-2028)
        6.3.2 North America Hereditary Angioedema Treatment Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Hereditary Angioedema Treatment Market Size by Type
        7.1.1 Europe Hereditary Angioedema Treatment Sales by Type (2017-2028)
        7.1.2 Europe Hereditary Angioedema Treatment Revenue by Type (2017-2028)
    7.2 Europe Hereditary Angioedema Treatment Market Size by Application
        7.2.1 Europe Hereditary Angioedema Treatment Sales by Application (2017-2028)
        7.2.2 Europe Hereditary Angioedema Treatment Revenue by Application (2017-2028)
    7.3 Europe Hereditary Angioedema Treatment Market Size by Country
        7.3.1 Europe Hereditary Angioedema Treatment Sales by Country (2017-2028)
        7.3.2 Europe Hereditary Angioedema Treatment Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Hereditary Angioedema Treatment Market Size by Type
        8.1.1 Asia Pacific Hereditary Angioedema Treatment Sales by Type (2017-2028)
        8.1.2 Asia Pacific Hereditary Angioedema Treatment Revenue by Type (2017-2028)
    8.2 Asia Pacific Hereditary Angioedema Treatment Market Size by Application
        8.2.1 Asia Pacific Hereditary Angioedema Treatment Sales by Application (2017-2028)
        8.2.2 Asia Pacific Hereditary Angioedema Treatment Revenue by Application (2017-2028)
    8.3 Asia Pacific Hereditary Angioedema Treatment Market Size by Region
        8.3.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region (2017-2028)
        8.3.2 Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Hereditary Angioedema Treatment Market Size by Type
        9.1.1 Latin America Hereditary Angioedema Treatment Sales by Type (2017-2028)
        9.1.2 Latin America Hereditary Angioedema Treatment Revenue by Type (2017-2028)
    9.2 Latin America Hereditary Angioedema Treatment Market Size by Application
        9.2.1 Latin America Hereditary Angioedema Treatment Sales by Application (2017-2028)
        9.2.2 Latin America Hereditary Angioedema Treatment Revenue by Application (2017-2028)
    9.3 Latin America Hereditary Angioedema Treatment Market Size by Country
        9.3.1 Latin America Hereditary Angioedema Treatment Sales by Country (2017-2028)
        9.3.2 Latin America Hereditary Angioedema Treatment Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Hereditary Angioedema Treatment Market Size by Type
        10.1.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Type (2017-2028)
    10.2 Middle East and Africa Hereditary Angioedema Treatment Market Size by Application
        10.2.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Application (2017-2028)
    10.3 Middle East and Africa Hereditary Angioedema Treatment Market Size by Country
        10.3.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CSL
        11.1.1 CSL Corporation Information
        11.1.2 CSL Overview
        11.1.3 CSL Hereditary Angioedema Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CSL Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CSL Recent Developments
    11.2 Pharming Group
        11.2.1 Pharming Group Corporation Information
        11.2.2 Pharming Group Overview
        11.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pharming Group Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pharming Group Recent Developments
    11.3 Shire plc (Takeda Pharmaceutical Company Limited)
        11.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
        11.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Overview
        11.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
    11.4 Ionis Pharmaceuticals
        11.4.1 Ionis Pharmaceuticals Corporation Information
        11.4.2 Ionis Pharmaceuticals Overview
        11.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Ionis Pharmaceuticals Recent Developments
    11.5 Attune Pharmaceuticals
        11.5.1 Attune Pharmaceuticals Corporation Information
        11.5.2 Attune Pharmaceuticals Overview
        11.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Attune Pharmaceuticals Recent Developments
    11.6 BioCryst Pharmaceuticals
        11.6.1 BioCryst Pharmaceuticals Corporation Information
        11.6.2 BioCryst Pharmaceuticals Overview
        11.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 BioCryst Pharmaceuticals Recent Developments
    11.7 KalVista Pharmaceuticals
        11.7.1 KalVista Pharmaceuticals Corporation Information
        11.7.2 KalVista Pharmaceuticals Overview
        11.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 KalVista Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Hereditary Angioedema Treatment Industry Chain Analysis
    12.2 Hereditary Angioedema Treatment Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Hereditary Angioedema Treatment Production Mode & Process
    12.4 Hereditary Angioedema Treatment Sales and Marketing
        12.4.1 Hereditary Angioedema Treatment Sales Channels
        12.4.2 Hereditary Angioedema Treatment Distributors
    12.5 Hereditary Angioedema Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Hereditary Angioedema Treatment Industry Trends
    13.2 Hereditary Angioedema Treatment Market Drivers
    13.3 Hereditary Angioedema Treatment Market Challenges
    13.4 Hereditary Angioedema Treatment Market Restraints
14 Key Findings in The Global Hereditary Angioedema Treatment Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Hereditary Angioedema Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
    Table 3. Major Manufacturers of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
    Table 4. Major Manufacturers of Kallikrein Inhibitors (Kalbitor, Takhzyro)
    Table 5. Major Manufacturers of Others (Conventional Drugs, Pipeline Drugs)
    Table 6. Global Hereditary Angioedema Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Hereditary Angioedema Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Hereditary Angioedema Treatment Sales by Region (2017-2022) & (K Units)
    Table 9. Global Hereditary Angioedema Treatment Sales Market Share by Region (2017-2022)
    Table 10. Global Hereditary Angioedema Treatment Sales by Region (2023-2028) & (K Units)
    Table 11. Global Hereditary Angioedema Treatment Sales Market Share by Region (2023-2028)
    Table 12. Global Hereditary Angioedema Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2017-2022)
    Table 14. Global Hereditary Angioedema Treatment Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2023-2028)
    Table 16. Global Hereditary Angioedema Treatment Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Hereditary Angioedema Treatment Sales Share by Manufacturers (2017-2022)
    Table 18. Global Hereditary Angioedema Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers (2017-2022)
    Table 20. Hereditary Angioedema Treatment Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2021)
    Table 23. Hereditary Angioedema Treatment Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Hereditary Angioedema Treatment Product Offered
    Table 25. Date of Manufacturers Enter into Hereditary Angioedema Treatment Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Hereditary Angioedema Treatment Sales by Type (2017-2022) & (K Units)
    Table 28. Global Hereditary Angioedema Treatment Sales by Type (2023-2028) & (K Units)
    Table 29. Global Hereditary Angioedema Treatment Sales Share by Type (2017-2022)
    Table 30. Global Hereditary Angioedema Treatment Sales Share by Type (2023-2028)
    Table 31. Global Hereditary Angioedema Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Hereditary Angioedema Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Hereditary Angioedema Treatment Revenue Share by Type (2017-2022)
    Table 34. Global Hereditary Angioedema Treatment Revenue Share by Type (2023-2028)
    Table 35. Hereditary Angioedema Treatment Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Hereditary Angioedema Treatment Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Hereditary Angioedema Treatment Sales by Application (2017-2022) & (K Units)
    Table 38. Global Hereditary Angioedema Treatment Sales by Application (2023-2028) & (K Units)
    Table 39. Global Hereditary Angioedema Treatment Sales Share by Application (2017-2022)
    Table 40. Global Hereditary Angioedema Treatment Sales Share by Application (2023-2028)
    Table 41. Global Hereditary Angioedema Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Hereditary Angioedema Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Hereditary Angioedema Treatment Revenue Share by Application (2017-2022)
    Table 44. Global Hereditary Angioedema Treatment Revenue Share by Application (2023-2028)
    Table 45. Hereditary Angioedema Treatment Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Hereditary Angioedema Treatment Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Hereditary Angioedema Treatment Sales by Type (2017-2022) & (K Units)
    Table 48. North America Hereditary Angioedema Treatment Sales by Type (2023-2028) & (K Units)
    Table 49. North America Hereditary Angioedema Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Hereditary Angioedema Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Hereditary Angioedema Treatment Sales by Application (2017-2022) & (K Units)
    Table 52. North America Hereditary Angioedema Treatment Sales by Application (2023-2028) & (K Units)
    Table 53. North America Hereditary Angioedema Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Hereditary Angioedema Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Hereditary Angioedema Treatment Sales by Country (2017-2022) & (K Units)
    Table 56. North America Hereditary Angioedema Treatment Sales by Country (2023-2028) & (K Units)
    Table 57. North America Hereditary Angioedema Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Hereditary Angioedema Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Hereditary Angioedema Treatment Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Hereditary Angioedema Treatment Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Hereditary Angioedema Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Hereditary Angioedema Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Hereditary Angioedema Treatment Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Hereditary Angioedema Treatment Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Hereditary Angioedema Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Hereditary Angioedema Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Hereditary Angioedema Treatment Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Hereditary Angioedema Treatment Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Hereditary Angioedema Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Hereditary Angioedema Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Hereditary Angioedema Treatment Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Hereditary Angioedema Treatment Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Hereditary Angioedema Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Hereditary Angioedema Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Hereditary Angioedema Treatment Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Hereditary Angioedema Treatment Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Hereditary Angioedema Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Hereditary Angioedema Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Hereditary Angioedema Treatment Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Hereditary Angioedema Treatment Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Hereditary Angioedema Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Hereditary Angioedema Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Hereditary Angioedema Treatment Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Hereditary Angioedema Treatment Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Hereditary Angioedema Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Hereditary Angioedema Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Hereditary Angioedema Treatment Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Hereditary Angioedema Treatment Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Hereditary Angioedema Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Hereditary Angioedema Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Hereditary Angioedema Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Hereditary Angioedema Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Hereditary Angioedema Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Hereditary Angioedema Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 107. CSL Corporation Information
    Table 108. CSL Description and Major Businesses
    Table 109. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. CSL Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. CSL Recent Developments
    Table 112. Pharming Group Corporation Information
    Table 113. Pharming Group Description and Major Businesses
    Table 114. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Pharming Group Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Pharming Group Recent Developments
    Table 117. Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
    Table 118. Shire plc (Takeda Pharmaceutical Company Limited) Description and Major Businesses
    Table 119. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
    Table 122. Ionis Pharmaceuticals Corporation Information
    Table 123. Ionis Pharmaceuticals Description and Major Businesses
    Table 124. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Ionis Pharmaceuticals Recent Developments
    Table 127. Attune Pharmaceuticals Corporation Information
    Table 128. Attune Pharmaceuticals Description and Major Businesses
    Table 129. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Attune Pharmaceuticals Recent Developments
    Table 132. BioCryst Pharmaceuticals Corporation Information
    Table 133. BioCryst Pharmaceuticals Description and Major Businesses
    Table 134. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. BioCryst Pharmaceuticals Recent Developments
    Table 137. KalVista Pharmaceuticals Corporation Information
    Table 138. KalVista Pharmaceuticals Description and Major Businesses
    Table 139. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. KalVista Pharmaceuticals Recent Developments
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Hereditary Angioedema Treatment Distributors List
    Table 145. Hereditary Angioedema Treatment Customers List
    Table 146. Hereditary Angioedema Treatment Market Trends
    Table 147. Hereditary Angioedema Treatment Market Drivers
    Table 148. Hereditary Angioedema Treatment Market Challenges
    Table 149. Hereditary Angioedema Treatment Market Restraints
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hereditary Angioedema Treatment Product Picture
    Figure 3. Global Hereditary Angioedema Treatment Market Share by Type in 2021 & 2028
    Figure 3. C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Picture
    Figure 4. Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Picture
    Figure 5. Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Picture
    Figure 6. Others (Conventional Drugs, Pipeline Drugs) Product Picture
    Figure 7. Global Hereditary Angioedema Treatment Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacies
    Figure 9. Retail Pharmacies
    Figure 10. Others (online pharmacies, mail pharmacies)
    Figure 11. Hereditary Angioedema Treatment Report Years Considered
    Figure 12. Global Hereditary Angioedema Treatment Sales 2017-2028 (K Units)
    Figure 13. Global Hereditary Angioedema Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Hereditary Angioedema Treatment Revenue 2017-2028 (US$ Million)
    Figure 15. Global Hereditary Angioedema Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Hereditary Angioedema Treatment Sales Market Share by Region (2017-2022)
    Figure 17. Global Hereditary Angioedema Treatment Sales Market Share by Region (2023-2028)
    Figure 18. North America Hereditary Angioedema Treatment Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Hereditary Angioedema Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Hereditary Angioedema Treatment Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Hereditary Angioedema Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Hereditary Angioedema Treatment Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Hereditary Angioedema Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Hereditary Angioedema Treatment Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Hereditary Angioedema Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Hereditary Angioedema Treatment Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Hereditary Angioedema Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Hereditary Angioedema Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Hereditary Angioedema Treatment in the World: Market Share by Hereditary Angioedema Treatment Revenue in 2021
    Figure 30. Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Hereditary Angioedema Treatment Sales Market Share by Type (2017-2028)
    Figure 32. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2028)
    Figure 33. Global Hereditary Angioedema Treatment Sales Market Share by Application (2017-2028)
    Figure 34. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2017-2028)
    Figure 35. North America Hereditary Angioedema Treatment Sales Market Share by Type (2017-2028)
    Figure 36. North America Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2028)
    Figure 37. North America Hereditary Angioedema Treatment Sales Market Share by Application (2017-2028)
    Figure 38. North America Hereditary Angioedema Treatment Revenue Market Share by Application (2017-2028)
    Figure 39. North America Hereditary Angioedema Treatment Sales Share by Country (2017-2028)
    Figure 40. North America Hereditary Angioedema Treatment Revenue Share by Country (2017-2028)
    Figure 41. U.S. Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2017-2028)
    Figure 44. Europe Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2017-2028)
    Figure 46. Europe Hereditary Angioedema Treatment Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Hereditary Angioedema Treatment Sales Share by Country (2017-2028)
    Figure 48. Europe Hereditary Angioedema Treatment Revenue Share by Country (2017-2028)
    Figure 49. Germany Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 50. France Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Hereditary Angioedema Treatment Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Hereditary Angioedema Treatment Revenue Share by Region (2017-2028)
    Figure 60. China Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 63. India Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Hereditary Angioedema Treatment Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Hereditary Angioedema Treatment Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Hereditary Angioedema Treatment Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Hereditary Angioedema Treatment Sales Share by Country (2017-2028)
    Figure 75. Latin America Hereditary Angioedema Treatment Revenue Share by Country (2017-2028)
    Figure 76. Mexico Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Hereditary Angioedema Treatment Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Hereditary Angioedema Treatment Revenue Share by Country (2017-2028)
    Figure 85. Turkey Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Hereditary Angioedema Treatment Revenue (2017-2028) & (US$ Million)
    Figure 88. Hereditary Angioedema Treatment Value Chain
    Figure 89. Hereditary Angioedema Treatment Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Frequently Asked Questions
Hereditary Angioedema Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Angioedema Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Angioedema Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Escape Room

Escape Room market is segmented by players, region (country), by Type and by Application. Players ... Read More